Stockreport

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche will continue its dialogue with the EMA to explore a potential path forward to make Elevidys available to individuals living with DMD in the EU Roche believes t [Read more]